ondansetron has been researched along with Thyrotoxicosis in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Thyrotoxicosis: A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hays, HL | 1 |
| Jolliff, HA | 1 |
| Casavant, MJ | 1 |
1 other study available for ondansetron and Thyrotoxicosis
| Article | Year |
|---|---|
Thyrotoxicosis after a massive levothyroxine ingestion in a 3-year-old patient.
Topics: Antiemetics; Child, Preschool; Combined Modality Therapy; Dehydration; Drug Overdose; Emergencies; E | 2013 |